Since STZ-induced T1D pathology reduced SP burden in APP/PS1 mice (Additional file 1: Figure S1B), we hypothesized that this alteration in pathology would be accompanied by an enhanced neuroinflammatory response in APP/PS1-STZ mice compared to APP/PS1 mice at the 26-week time point. The gene discussed is APP; the disease is type 1 diabetes mellitus.